Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.
Don't take our word for it. Past attendees comment on the event. J. June, CEO of Ischemia Care, said, "Great networking, venue was outstanding, a lot of fun. This was without a doubt the best event of its type I have ever attended." And P. Burton, CEO of ResQ Pharma, said, "Very well managed. Speakers and panelists were outstanding. Content and subject matters covered during presentations were excellent. Overall I had an outstanding experience!"
Hear from healthcare executives such as Dave Jacobs, co-founder of Homethrive, EY Global Health Leader Aloha McBride, and Worksite Labs CEO Gary Frazier on how they are meeting the challenges of healthcare innovation.
The ViVE conference in Nashville, powered by HLTH and CHIME, offered an overview of the latest developments in health tech spanning interoperability, cybersecurity, price transparency, behavioral health and health equity.
By supporting next-generation payment methods that boost security and convenience for consumers, providers can enhance patient satisfaction and loyalty.
Inato recently raised $20 million in Series A2 funding for its tech platform, which enables access to inclusive clinical trials. The two-way platform brings exposure to community-based providers who often are overlooked by Big Pharma for clinical trial sites by allowing providers to apply for clinical trials in which they're interested.
In this month's episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Tom Richards, who recently became the new executive vice president of business development at Transcarent after spending more than 35 years at Cigna.
.jpg)
No comments:
Post a Comment